News brief
On January 20, according to TechCrunch, OpenAI acquired the life science AI agent company Orchestra Bio for an undisclosed amount; the team and technology were merged into Rosalind and related workbench. Orchestra was previously reported to have raised approximately USD 20 million in total financing (10, 2026).
Connected profiles
Explore
Sources · 1Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
- techcrunch.com ↗Published Oct 20, 2026
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
2026年10月20日，据 TechCrunch，OpenAI 收购生命科学 AI agent 公司 Orchestra Bio，金额未披露；团队与技术并入 Rosalind 及相关工作台。Orchestra 此前据报道累计融资约 2000 万美元。